Akoya Biosciences

Akoya Receives CLIA Certification for Biopharma Solutions Laboratory

The company said the certification would allow it to support later-stage clinical trials with its biopharma partners and was a step toward advancing its platform for clinical use.

Akoya Biosciences Q3 Revenues Rise 35 Percent

The spatial biology firm posted revenues of $13.5 million, up from $10.0 million in the year-ago period, and placed a total of 33 instruments.

People in the News: New Appointments at Roswell Biotechnologies, 23andMe, Akoya Biosciences, More

People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More

CrestOptics, Akoya Biosciences Collaborating on Spatial Biology Technologies

Akoya will integrate CrestOptics' instrumentation, including its spinning disk microscopy technology, to provide improved single-cell, multiplex protein imaging tools.

Jun 25, 2021

People in the News: New Appointments at 23andMe, GenapSys, Akoya Biosciences, More

Jun 10, 2021

Akoya Using $153M IPO Funding to Expand Commercial Reach, Drive Technology Development
Premium

Jun 4, 2021

Akoya Biosciences, AstraZeneca Collaborate on Spatial Biomarker Profiling for Immuno-Oncology

May 18, 2021

Akoya Biosciences Q1 Revenues Rise 11 Percent

May 17, 2021

Akoya Biosciences Inks Comarketing Deal for Tissue Imaging Tech With Zeiss

May 11, 2021

JP Morgan, Canaccord Genuity Initiate Coverage of Akoya Biosciences With Overweight, Buy Ratings

Jul 29, 2020

Akoya Biosciences, UCSF Launch Predictive Cancer Biomarker Collaboration

Dec 5, 2019

Akoya Biosciences Closes $50M Funding Round

Nov 5, 2019

Akoya Biosciences, Precision for Medicine to Develop Liquid Biopsy, Tissue Biomarker Tests

Oct 31, 2018

PerkinElmer Revenues Grow 22 Percent, Diagnostics Up 59 Percent

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.